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Abstract
Background: Coronary artery disease (CAD) is the most common cardiovascular disorder in adults. This study was performed to
elucidate the role of active leptin, homocysteine, galectin-3, total phospholipids, total, bound, free hexosamines, free-to-bound
hexosamines ratio in the pathogenesis of chronic myocardial ischemia and studying the effect of coronary artery bypass graft-
ing (CABG) on their serum levels.
Methods: A prospective case control study was carried out on 100 ischemic heart disease male patients undergoing elective CABG
and 25 healthy males. Serum levels of total phospholipids, total and free hexosamines, were estimated using spectrophotometric
methods, while, serum levels of active leptin, homocysteine and galectin-3 were estimated using ELISA assay kit.
Results: Significant higher serum active leptin, homocysteine, galectin-3, free hexosamines and free to bound hexosamines ratio
levels preoperatively when compared with the control group (p < 0.01 for all) with significant lowering of their serum levels
following CABG (p < 0.01 for all) except for active leptin. Significant lower serum total phospholipids, total and bound hexos-
amines levels preoperatively when compared with the control group (p < 0.01 for all) with significant elevations in their serum
levels following CABG (p < 0.01 for all).
Conclusions: High active leptin, homocysteine, galectin-3, free and free to bound hexosamines ratio and low total phospholipids,
total and bound hexosamines play an important role in the pathogenesis of myocardial ischemia. The serum levels of homocysteine,
galectin-3, hexosamines and total phospholipids, but not active leptin are significantly lowered following CABG.
Copyright © 2016, The Egyptian Society of Cardio-thoracic Surgery. Publishing services by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Coronary artery disease (CAD) is the most common cardiovascular disorder in adults. It is caused by the build-up
of cholesterol deposits in the wall of the coronary arteries. CAD often results in heart attack (myocardial infarction) or
chest pain (angina pectoris), even in the absence of prior symptoms [1]. Treatment for CAD can include changes in life
style, diet modification, weight reduction, and cholesterol reduction [2], as well as control of diabetes and hyper-
tension. Smoking cessation is also considered as an essential regimen [3]. Many patients can be adequately treated
with medications. Some individuals, however, will require invasive treatments such as percutaneous coronary
intervention (PCI) or coronary artery bypass grafting surgery (CABG) [4]. Cardiopulmonary bypass (CPB) is still
used in most CABG surgery. Hemodynamic and biochemical changes possibly caused by the CPB have been not
elucidated in details in literature [5].
Leptin is an adipose tissue derived hormone that plays a central role in regulating human energy homeostasis. The
role of leptin in regulating blood pressure, activating the sympathetic nervous system, insulin resistance, platelet
aggregation, arterial thrombosis, angiogenesis, and inflammatory vascular responses suggests that leptin may have a
close relationship with the development of CAD [6]. Because obesity and these metabolic syndrome traits predict
CAD, one might expect elevated leptin levels to be associated with ischemic heart disease (IHD) risk. Elevated leptin
indicates resistance to its beneficial action on appetite control and energy expenditure. Such an association would
potentially make leptin metabolism and action a target for therapeutic interventions and leptin levels a useful predictor
of IHD risk [7].
Hexosaminidase is responsible for removing the hexosamine, N-acetyl glucosamine (O-GlcNAc), from proteins,
releasing it into the free form. Elevated hexosaminidase expression significantly reduces the protein bounded form of
O-GlcNAc and increases the free form of O-GlcNAc leading to augmented post-ischemic cell death and antagonizes
post-ischemic cardiac myocyte survival [8].
Homocysteine is a sulfur-containing amino acid produced in the metabolism of the essential amino acid methionine
[9]. Homocysteine stimulates atherosclerosis by causing oxidative endothelial damage, altering the coagulation of
blood, and destruction of vascular matrix, thus promoting the thrombus-embolic diseases [10].
Galectin-3 “Gal-3” belongs to the family of b-galactoside binding proteins with an extended N-terminal region
and C-terminal domain, which is responsible for lectin activity [11]. In atherogenesis, Gal-3 has been reported
to have a multifaceted influence on both plaque formation and its destabilization [12]. It propagates vascular
inflammation, induces phenotypic changes in macrophages and supports transmigration of monocytes into the
vascular wall [13].
Phospholipids have amphiphilic properties, which might play a mediating role in the transport and removal of
hydrophobic neutral lipids, in particular of cholesterol esters, from vessel walls. Accordingly, high density lipoprotein
“HDL” with reduced phospholipid content has been found to be a poor receptor of cell cholesterol. Because of their
surface active properties, phospholipids also play an important role at all stages of coagulation and therefore are
probably essential for interactions between non-polar lipids and polar coagulation proteins. Such interactions may be
important in view of the contribution of thrombosis to arteriosclerosis, of the thrombotic origin of myocardial
infarction and unstable angina, and of the poor lysability of platelet-rich thrombi [14].
Based on literature, the present study assesses and confirms the role of a group of biochemical markers, in the form
of active leptin, homocysteine, galectin-3, total phospholipids, total, bound, free hexosamines and free-to-bound
hexosamines ratio in the pathogenesis of chronic myocardial ischemia and explore whether CABG could change
their serum levels or not since this couldn't be traced in literature.
2. Patients and methods
2.1. Participant patient population
This is a prospective case control study which was carried out from December 2011 to March 2016 in the
department of Cardiothoracic surgery-Faculty of Medicine- Assiut University. The study included 100 patients who
underwent CABG and formed the study group (group 1). These patients were compared with 25 age-matched,
apparently healthy males forming the control group (group 2). The study was approved by university hospital
ethics committee and informed consents were obtained from the included patients.
209A. Farouk et al. / Journal of the Egyptian Society of Cardio-Thoracic Surgery 24 (2016) 207e2142.2. Exclusion criteria
Patients with previous cardiac surgery, ejection fraction less than 40%, chronic renal insufficiency (serum creat-
inine >1.7 mg/dl) or renal failure on dialysis or use of steroids were excluded from the study.
2.3. Data collections
For each included patient, complete history taking, general and systemic examination, E.C.G, chest X-ray and
echocardiographywere done; hemodynamic data were recorded as regard heart rate, arterial blood pressure and central
venous pressure preoperative, 30min, one hour and six hours postoperative. This is in addition to routine blood analysis
preoperatively in the form of complete blood count, liver and kidney function tests, serum sodium and potassium.
2.4. Laboratory measures
Three cc venous blood was drawn from all patients (preoperative and 15 days postoperative) and control group, on
plane tubes, for serial assays of active leptin, total and free hexosamines, homocysteine, galectin-3 and total phos-
pholipids. Blood samples were then centrifuged at 3500 rpm for 15 min at 4 C and the sera were transferred into 1 ml
cryotubes, and stored at 80 C for later analyses.
Serum human active leptin (DSL-10-23100 supplied by diagnostic systems laboratories, Inc.), serum galectin-3 levels
were determined using human galactin-3 ELISA kit (WKEA MED supplies corp. USA) according to manufacturer's
protocol [provided byWKEAMEDsupplies corp.NewYork.USA] and serum homocysteine levelsweremeasured using
an enzyme-linked immune-sorbent (ELISA) assay kit, provided byChongqing Biospes Co., Ltd. ParadiseWalk, Jiangbei
District, Chongqing, 400020, Chin. All previously mentioned biochemical markers were measured using enzyme-linked
immune-sorbent assay (ELISA) multiskan EX microplate photomter, thermo scientific, STAT FAX-2100, USA.
Total phospholipids using kit provided from ELITECH Diagnostic, catalog no. 0030, total hexosamines were
estimated according to Gatt and Berman method [15] and free hexosamines were estimated as for total hexosamines
after precipitation of plasma proteins by 10% trichloroacetic acid “TCA”. All previously mentioned biochemical
markers were measured using T60 UV visible spectrophotometer (PG INSTRUMENTS LIMITED, alma park wibtoft,
Leicester shreshire, England. LE17SBE. Serial No. 20-1650-01-0010).
2.5. Anesthesia technique
Anesthetic management was uniform in all patients. All patients were premedicated with intravenous midazolam
(0.03 mg/kg) 30 min before the operation. Anesthesia was induced with fentanyl (3 mg/kg) combined with propofol
(2 mg/kg). Endotracheal intubation was performed after achieving muscle relaxant with recuronium bromide (1 mg/
kg). Mechanical ventilation was used to maintain eucapnia. Anesthesia was maintained by using continuous infusion
of fentanyl (1 mg/kg/hour) and propofol (2e8 mg/kg/hour). Fentanyl infusion was continued postoperative in the
intensive care unit (I.C.U).
2.6. Surgical procedure
All patients had median sternotomy. Standard cannulation was done. An initial dose of 400 mg/kg heparin was
used to obtain an activated clotting time. Range blood pressure of 50e70 mmHg and blood flow 2e2.4 L/min.
Priming solution contains mannitol and heparin. Hypothermia for 25e30 min. Cold (4 C) crystalloid cardioplegic
arrest was used after aortic cross clamping. Coronary bypass grafting was done using venous and arterial conduits.
Flow up in the I.C.U for the hemodynamic changes in the heart rate, arterial blood pressure and central venous
pressure. Antipyretics and potent antibiotic therapy were given. Before discharge the patient must meet the
followings: aware, impulsive breathing, detached endotracheal tube.
2.7. Statistical analysis
Statistical analysis was performed using Statistical Package for the Social Sciences (SPSS-version 17) software.
The results were expressed as mean ± standard deviation. One way ANOVA (analysis of variance) test was used to
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lation analysis was used to evaluate the correlations between different parameters. P values of less than 0.05 were
considered significant.
3. Results
3.1. Baseline characteristics
All patients were males with their mean age 51.52 ± 13.76 years and their mean body mass index (BMI)
25.43 ± 2.33. The mean bypass and whole surgery times were 142.78 ± 7.22, 344.5 ± 25.8 min respectively, whereas
the mean (I.C.U) stay and ward stay were 2.48 ± 0.51and 13.17 ± 1.67 days respectively (Table 1). No deaths in the
studied patients and all the patients involved completed the study.
3.2. Perioperative hemodynamic changes
The mean ± SD of some hemodynamic parameters of the patients preoperatively, 30 min, one hour and six hours
postoperatively, were presented in Table 2 and Fig. 1, which reveal significant hemodynamic changes regarding the
heart rate, arterial blood pressure and central venous pressure, preoperative versus postoperative recordings.
3.3. Serial serum levels of active leptin, homocysteine, galectin-3, total phospholipids, total, bound, free hexos-
amines, free-to-bound hexosamines ratio
Results of the serum levels of active leptin, homocysteine, galectin-3 and total phospholipids, both preoperatively
and postoperatively compared with the control group were presented in Table 3. Preoperative serum active leptin,
homocysteine and galectin-3 levels were significantly higher in the CABG group than in the control group. These
levels decreased significantly after the operation without reaching the serum levels in the control group. The only
exception is the active leptin which revealed no significant serum level changes postoperatively. In addition, there
were significant lower serum total phospholipids levels preoperatively when compared with the control group. These
levels showed significant postoperative elevations without reaching the levels of the control group. Results of the
serum levels of hexosamines (total, free, bound, free to bound ratio), both preoperatively and postoperatively
compared with the control group were presented in Table 4. Preoperative serum free hexosamines levels and free to
bound hexosamines ratio were significantly higher in the CABG group than in the control group. These levels
decreased significantly after the operation without reaching the serum levels in the control group. In addition, there
were significant lower serum total and bound hexosamines levels preoperatively when compared with the control
group. These levels showed significant postoperative elevations without reaching he levels of the control group.
4. Discussion
The literature offers no detailed data about the effects of CPB andCABG on hemodynamic changes [5]. In our study,
the hemodynamic parameters of the studied patients including heart rate, arterial blood pressure and central venous
pressure were recorded, the mean heart rate was significantly higher one hour postoperatively when compared with the
heart rate preoperatively, 30 min and six hours postoperatively (p < 0.01). The mean arterial blood pressure wasTable 1
Baseline characteristics of patients.
Variables Minimum Maximum Mean ± SD
Age (years) 33.00 71.00 51.52 ± 13.76
BMI 21.00 30.00 25.43 ± 2.33
Time of bypass (Min) 130.00 157.00 142.78 ± 7.22
Time of surgery (Min) 310.00 390.00 344.5 ± 25.8
ICU stay (days) 2.00 3.00 2.48 ± 0.51
Ward stay (days) 11.00 16.00 13.17 ± 1.67
Table 2
Recorded hemodynamic parameters of the patients preoperative, 30 min, one hour and six hours postoperative, using one way analysis of variance
“ANOVA” followed by LSD multiple comparisons.
Hemodynamic parameters Before 30 min One hour Six hours P-value
Heart rate “Beat/min” 85.4 ± 4 78.3 ± 4.4 94.7 ± 3.8 83.1 ± 3 0.000**
Arterial Blood Pressure “mmHg” 85.6 ± 2.8 75.1 ± 2.6 67.9 ± 2.7 70.9 ± 1.3 0.000**
Central Venous Pressure “mmHg” 9.1 ± 0.3 9.1 ± 0.3 8.1 ± 0.3 8.7 ± 0.2 0.000**
*Indicate significant change at P < 0.05; ** indicate significant change at p < 0.01; *** indicate significant change at p < 0.001. NS means non
significant ((p > 0.05).
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operatively (p < 0.01). The mean central venous pressure was significantly lower one hour postoperatively versus the
preoperative, 30 min and six hours postoperatively (p < 0.01). These findings were in agreement with Aydin et al. [5].
The findings of our study revealed a significant higher serum active leptin, homocysteine and galectin-3 levels with
significant lower serum levels of total phospholipids among the IHD patients preoperatively when compared with the
control group. These findings confirm that these biochemical parameters play an essential role in the pathogenesis of
chronic cardiac ischemia with different mechanisms.
For leptin, our findings were in agreement withWolk et al. [16] and Khafaji et al. [17]. A Study done by Stangl et al.
[18] found that patients with CAD exhibited higher serum leptin concentrations than controls matched for age, gender
and BMI, suggesting that leptin could contribute to the development of cardiovascular disease, possibly via activation
of the sympathetic nervous system. Vavruch et al. [19], reported that high leptin levels were related to increased risks
of IHD independently of traditional risk factors in men.Fig. 1. Comparison of the mean hemodynamic parameters of the patients preoperative, 30 min, one hour and six hours postoperative. A: Central
venous pressure “mmHg”, B: Heart rate “beat/min”, C: Arterial blood pressure “mmHg”, D: The three hemodynamic parameters all together.
Table 3
Comparison of the serum levels of active leptin, homocysteine, galectin-3 and total phospholipids preoperative and postoperative versus the control
group, using one way analysis of variance “ANOVA” followed by LSD multiple comparisons.
Biochemical parameters Control group (n ¼ 25) Patients (n ¼ 100) P1 P2
Preoperative Post-operative
Active Leptin “ng/ml” 7.78 ± 2.22 32.48 ± 8.59 32.26 ± 7.50 0.000** 0.645 NS
Homocysteine, “mmol/L” 9.17 ± 1.24 14.04 ± 1.58 13.3 ± 1.56 0.000** 0.000**
Galectin-3, “ng/ml” 5.48 ± 1.68 25.96 ± 8.06 23.79 ± 7.95 0.000** 0.001**
Total phospholipids, “g/l” 8.42 ± 1.64 2.47 ± 0.72 2.7 ± 0.76 0.000** 0.006**
P1¼ Control versus Preoperative.
P2¼ Preoperative versus Postoperative.
*Indicate significant change at P < 0.05; ** indicate significant change at p < 0.01; *** indicate significant change at p < 0.001. NS means non
significant (p > 0.05).
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[21], who found that plasma Hcy concentrations were significantly higher in patients with myocardial infarction than
in controls.
Myocardial injury generates inflammatory signals that recruit activated macrophages to the myocardium. Medi-
ators such as osteopontin stimulate these macrophages to secrete galectin-3. Galectin-3 may be particularly important
in patients with IHD in whom there is sufficient inflammatory substrate for macrophage recruitment and subsequent
galectin-3 secretion [22]. The findings of our study suggest for the first time that circulating galectin-3 levels can be
used as a marker for chronic IHD as its serum levels were significantly higher among patients with chronic cardiac
ischemia when compared with the control group, although it is more valuable diagnostic and prognostic biomarker in
heart failure patients. The use of galectin-3 as a marker of chronic cardiac ischemia needs further assessments.
For total phospholipids, our findings were in agreement with Papathanasiou et al. [23]. Also a study by Nagao et al.
[24], who reported a significant decrease in the amounts of total phospholipids in the mitochondrial fractions prepared
from ischemic myocardial in an ischemic myocardial model, suggesting that disturbances in phospholipid metabolism
may be one of the critical alterations that produce irreversible injury during ischemia.
Interestingly, activation of hexosamine biosynthesis pathway (HBP) and increase in the level of O-linked-N-
acetylglucosamine (O-GlcNAc) on serine and threonine residues of cytoplasmic and nuclear proteins (which represent
bounded form of hexosamines), have been associated with increased tolerance of cells to stress [25], and some studies
have suggested it might be also associated with ischemic cardioprotection [26]. Regarding hexsoamines serum levels,
the findings of our study revealed significant lower serum total and bound hexosamines levels preoperatively when
compared with the control group (p < 0.01), which indicate that total and bound hexosamines (in the form of gly-
coproteins and proteoglycans) play an important role in protection against cardiac ischemia. At the same time there
were significant higher serum free hexosamines and free to bound hexosamines ratio preoperatively when compared
with the control group (p < 0.01), which indicate that free hexosamines in the form of glucosamines and galactos-
amines are implicated in the pathogenesis of cardiac ischemia.Table 4
Comparison of the serum levels of hexosamines (total, free, bound, free to bound ratio) preoperative and postoperative versus the control group,
using one way analysis of variance “ANOVA” followed by LSD multiple comparisons.
Biochemical parameters Control group (n ¼ 25) Patients (n ¼ 100) P1 P2
Preoperative Post-operative
Hexosamines (total), mg/dl 90.3 ± 24.5 58.3 ± 7.4 60.4 ± 7.633 <0.001** 0.002**
Hexsoamines (free), mg/dl 0.796 ± 0.2 1.6 ± 0.7 0.765 ± 0.21 <0.001** <0.001**
Hexosamines (bound), mg/dl 89.5 ± 24.5 56.7 ± 7.5 59.67 ± 7.5 <0.001** <0.001**
Free to bound hexosamines ratio 0.009 ± 0.003 0.03 ± 0.016 0.013 ± 0.003 <0.001** <0.001**
P1¼ Control versus Preoperative.
P2¼ Preoperative versus Postoperative.
*Indicate significant change at P < 0.05; ** indicate significant change at p < 0.01; *** indicate significant change at p < 0.001. NS means non
significant ((p > 0.05).
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serum levels of the ischemic biochemical parameters that have been measured in the present study, except for ho-
mocysteine. The present study revealed significant lowering in the serum levels of galectin-3, free hexosamines and
free to bound hexosamines ratio and significant increasing in the serum levels of total phospholipids, total and bound
hexosamines (p < 0.01 for each) following CABG when compared with the preoperative serum levels but still not
reaching the serum levels of the control. Regarding the serum levels of homocysteine following CABG, the present
study revealed significantly lower levels when compared with the preoperative levels (p < 0.01). In agreement with
these findings, Parvizi et al. [27] who noticed a marked postoperative reduction of the plasma homocysteine levels in
patients undergoing CABG.
The findings of the present study revealed no significant postoperative changes in the serum level of active leptin.
Khafaji et al. [17] reported that no difference in the serum leptin between patients with acute myocardial infarction
who achieved coronary reperfusion using thrombolytic therapy versus those who don't achieve reperfusion, suggesting
that leptin is not released from the myocytes and concluding that serum leptin levels cannot be used as predictors for
coronary reperfusion.
4.1. Study limitations
These limitations include the small number of the included patients and short post-operative follow up, so repeated
measurements of such ischemic biomarkers 3e6 months post-CABG to confirm the present findings on a larger-scale
studies is recommended.
5. Conclusions
The findings of this study revealed significant hemodynamic changes regarding the heart rate, arterial blood
pressure and central venous pressure in patients undergoing CABG. Also, these findings prove that high active leptin,
homocysteine, galectin-3, free and free to bound hexosamines ratio and low total phospholipids, total and bound
hexosamines play an important role in the pathogenesis of myocardial ischemia. The serum levels of homocysteine,
galectin-3, hexosamines and total phospholipids, but not active leptin are significantly changed following CABG, so
their serum levels may be used as predictors for coronary reperfusion.
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